Stanley Druckenmiller's RVMD Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 399,587 shares of Revolution Medicines, Inc. (RVMD) worth $74.84 M, representing 1.44% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Stanley Druckenmiller has initiated a new position in RVMD, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 83,727 shares.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's Revolution Medicines (RVMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Revolution Medicines (RVMD) Trades by Stanley Druckenmiller
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +83,727 | Add 26.51% | 399,587 | $187.28 |
| Q1 2026 | +315,860 | New Buy | 315,860 | $97.25 |
Stanley Druckenmiller's Revolution Medicines Investment FAQs
Stanley Druckenmiller first purchased Revolution Medicines, Inc. (RVMD) in Q1 2026, acquiring 315,860 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held Revolution Medicines, Inc. (RVMD) for 2 quarters since Q1 2026.
Stanley Druckenmiller's largest addition to Revolution Medicines, Inc. (RVMD) was in Q1 2026, adding 315,860 shares worth $30.72 M.
According to the latest 13F filing for Q2 2026, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 399,587 shares of Revolution Medicines, Inc. (RVMD), valued at approximately $74.84 M.
As of the Q2 2026 filing, Revolution Medicines, Inc. (RVMD) represents approximately 1.44% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings.
Stanley Druckenmiller's peak holding in Revolution Medicines, Inc. (RVMD) was 399,587 shares, as reported at the end of Q2 2026.